Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000193
UniProt IDQ93050
Primary gene name(s)ATP6V0A1
Synonym gene name(s)ATP6N1, ATP6N1A, VPP1
Protein nameV-type proton ATPase 116 kDa subunit a isoform 1
Protein functionRequired for assembly and activity of the vacuolar ATPase. Potential role in differential targeting and regulation of the enzyme for a specific organelle, By similarity. {ECO:0000250}.
Subcellular locationCytoplasmic vesicle membrane;
Multi-pass membrane protein. Melanosome. Note=Coated vesicle. Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q93050
Gene Ontology
(Biological Process)
Complete annatation
ATP hydrolysis coupled proton transport [GO:0015991];
ATP synthesis coupled proton transport [GO:0015986];
insulin receptor signaling pathway [GO:0008286];
ion transmembrane transport [GO:0034220];
phagosome acidification [GO:0090383];
regulation of macroautophagy [GO:0016241];
toxin transport [GO:1901998];
transferrin transport [GO:0033572];
vacuolar acidification [GO:0007035];
vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]
Gene Ontology
(Molecular Function)
Complete annatation
ATPase binding [GO:0051117];
proton-transporting ATPase activity, rotational mechanism [GO:0046961]
Gene Ontology
(Cellular Component)
Complete annatation
cell [GO:0005623];
cytoplasm [GO:0005737];
endosome membrane [GO:0010008];
extracellular exosome [GO:0070062];
Golgi apparatus [GO:0005794];
integral component of membrane [GO:0016021];
intracellular membrane-bounded organelle [GO:0043231];
melanosome [GO:0042470];
nucleoplasm [GO:0005654];
phagocytic vesicle membrane [GO:0030670];
plasma membrane [GO:0005886];
vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220];
vacuolar proton-transporting V-type ATPase complex [GO:0016471]
Protein-protein interaction107018
Phylogenetic treeQ93050
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      Yes
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-1.853587187305211.43870101942944e-071.33605063246091e-06
AZA vs. DISU0.1771017909927440.5698313450835510.954304256505839
AZA vs. IL7-0.3074199119666090.4168984406931820.999311006273513
AZA vs. SAHA0.7902962217508850.008842895356972250.0904175287913247
DISU vs. CD32.018509735988651.04280789670064e-071.28846608482503e-06
DISU vs. IL7-0.4953347434914330.1449667311496690.495999426255391
DISU vs. SAHA0.6170863401918940.03569661827951990.230108666949989
DMSO vs. AZA0.0309233078846330.9253727020810781
DMSO vs. CD31.878845771093092.68021991267631e-082.61343126113065e-07
DMSO vs. DISU-0.1462718202262670.6109799011954020.939289650701039
DMSO vs. IL7-0.3318814238753230.3540179953300390.819033345549468
DMSO vs. SAHA0.7535362331885930.006003937301206070.0634094877830951
HIV vs. Mock in Activation0.6240711223509080.3265832882624530.999983755607037
HIV vs. Mock in Latency0.3611529193321490.1169345526256310.999834320637052
IL7 vs. CD31.548455160009233.12803916265869e-050.000210768593199618
SAHA vs. CD32.62177044971173.70248276482243e-121.02755829218921e-10
SAHA vs. IL71.096138707450590.00107460156438710.0122902458130282
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.336336 0.0481819
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
HIV-1 virus replication enhanced by expression of human gene 18187620

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00190 Oxidative phosphorylation - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)
hsa04142 Lysosome - Homo sapiens (human)
hsa04145 Phagosome - Homo sapiens (human)
hsa04721 Synaptic vesicle cycle - Homo sapiens (human)
hsa04966 Collecting duct acid secretion - Homo sapiens (human)
hsa05110 Vibrio cholerae infection - Homo sapiens (human)
hsa05120 Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human)
hsa05152 Tuberculosis - Homo sapiens (human)
hsa05323 Rheumatoid arthritis - Homo sapiens (human)
Menu